IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications1 with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.
October 2, 2018
· 2 min read